Letter: Adverse effects of Lomotil.
D001285:Atropine / Q000009:adverse effects* / Q000627:therapeutic use; D003092:Colitis / Q000139:chemically induced; D003093:Colitis, Ulcerative / Q000139:chemically induced; D003967:Diarrhea / Q000188:drug therapy; D004106:Dilatation; D004338:Drug Combinations; D004357:Drug Synergism; D004405:Dysentery, Bacillary / Q000188:drug therapy; D005243:Feces / Q000382:microbiology; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007223:Infant; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects; D007540:Isonipecotic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D008034:Lincomycin / Q000009:adverse effects; D010093:Oxolinic Acid / Q000009:adverse effects; D012008:Recurrence; D012760:Shigella / Q000472:pathogenicity
D004338:Drug Combinations; D005765:Gastrointestinal Agents; D007540:Isonipecotic Acids; D001285:Atropine; D008034:Lincomycin; D010093:Oxolinic Acid